(Q40273851)

English

Gene expression analysis using human cancer xenografts to identify novel predictive marker genes for the efficacy of 5-fluorouracil-based drugs

scientific article published on June 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

19 September 2017

Gene expression analysis using human cancer xenografts to identify novel predictive marker genes for the efficacy of 5-fluorouracil-based drugs (English)

1 reference

Europe PubMed Central

19 September 2017

1 reference

based on heuristic

inferred from title

author name string

Akio Ooyama

1

1 reference

Europe PubMed Central

19 September 2017

Teiji Takechi

2

1 reference

Europe PubMed Central

19 September 2017

Etsuko Toda

3

1 reference

Europe PubMed Central

19 September 2017

Hideki Nagase

4

1 reference

Europe PubMed Central

19 September 2017

Yoshihiro Okayama

5

1 reference

Europe PubMed Central

19 September 2017

Kenji Kitazato

6

1 reference

Europe PubMed Central

19 September 2017

Yoshikazu Sugimoto

7

1 reference

Europe PubMed Central

19 September 2017

Toshinori Oka

8

1 reference

Europe PubMed Central

19 September 2017

Masakazu Fukushima

9

1 reference

Europe PubMed Central

19 September 2017

publication date

1 June 2006

1 reference

Europe PubMed Central

19 September 2017

1 reference

Europe PubMed Central

19 September 2017

97

1 reference

Europe PubMed Central

19 September 2017

6

1 reference

Europe PubMed Central

19 September 2017

510-522

1 reference

Europe PubMed Central

19 September 2017

Molecular classification of cancer: class discovery and class prediction by gene expression monitoring

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00204.X

21 January 2018

Cancer pharmacogenetics: polymorphisms, pathways and beyond

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00204.X

21 January 2018

A phase I study of oral uracil-ftorafur plus folinic acid in combination with weekly paclitaxel in patients with solid tumors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00204.X

21 January 2018

Thymidylate synthetase: mechanism of inhibition by 5-fluoro-2'-deoxyuridylate.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00204.X

21 January 2018

Clinical studies of three oral prodrugs of 5-fluorouracil (capecitabine, UFT, S-1): a review

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00204.X

21 January 2018

A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00204.X

21 January 2018

Phase II study of oral S-1 for treatment of metastatic colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00204.X

21 January 2018

Early phase II study of S-1, a new oral fluoropyrimidine, for advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00204.X

21 January 2018

Identification of novel genes associated with the response to 5-FU treatment in gastric cancer cell lines using a cDNA microarray

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00204.X

21 January 2018

Thymidylate synthase (TS) and ribonucleotide reductase (RNR) may be involved in acquired resistance to 5-fluorouracil (5-FU) in human cancer xenografts in vivo

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00204.X

21 January 2018

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00204.X

21 January 2018

Relationship between protein levels and gene expression of dihydropyrimidine dehydrogenase in human tumor cells during growth in culture and in nude mice.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00204.X

21 January 2018

Identification of candidate predictive markers of anticancer drug sensitivity using a panel of human cancer cell lines

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00204.X

21 January 2018

Mechanisms of hypoxic gene regulation of angiogenesis factor Cyr61 in melanoma cells.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00204.X

21 January 2018

A gene expression database for the molecular pharmacology of cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00204.X

21 January 2018

Systematic variation in gene expression patterns in human cancer cell lines

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00204.X

21 January 2018

Responsiveness of human lung cancer/nude mouse to antitumor agents in a model using clinically equivalent doses

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00204.X

21 January 2018

Enhancement of the antitumour activity of 5-fluorouracil (5-FU) by inhibiting dihydropyrimidine dehydrogenase activity (DPD) using 5-chloro-2,4-dihydroxypyridine (CDHP) in human tumour cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00204.X

21 January 2018

Superior antitumour activity of S-1 in tumours with a high dihydropyrimidine dehydrogenase activity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00204.X

21 January 2018

Dihydropyrimidine dehydrogenase (DPD) activity in gastric cancer tissue and effect of DPD inhibitory fluoropyrimidines

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00204.X

21 January 2018

Overexpression of the cell adhesion molecules DDR1, Claudin 3, and Ep-CAM in metaplastic ovarian epithelium and ovarian cancer.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00204.X

21 January 2018

Cloning and expression of the mRNA of human galectin-4, an S-type lectin down-regulated in colorectal cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00204.X

21 January 2018

CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00204.X

21 January 2018

Genome-wide views of cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00204.X

21 January 2018

Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1 M tegafur-0.4 M gimestat-1 M otastat potassium) in advanced gastric cancer patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00204.X

21 January 2018

Molecular profiles of invasive mucinous and ductal carcinomas of the breast: a molecular case study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00204.X

21 January 2018

Anti-sense oligonucleotides directed against EGF-related growth factors enhance anti-proliferative effect of conventional anti-tumor drugs in human colon-cancer cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00204.X

21 January 2018

Identifiers

10.1111/J.1349-7006.2006.00204.X

1 reference

Europe PubMed Central

19 September 2017

1 reference

Europe PubMed Central

19 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40273851&oldid=1892346506"